+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hematologic abnormalities in patients with nonhematologic malignancies



Hematologic abnormalities in patients with nonhematologic malignancies



Hematology/Oncology Clinics of North America 1(2): 281-299



Hematologic abnormalities are not uncommon in patients with nonhematologic malignancies and may contribute significantly to morbidity and even to mortality. An appreciation for the spectrum of severity and etiology will allow the physician to anticipate and perhaps ameliorate some of these complications. This understanding will also provide sufficient information to decide when intervention is unnecessary.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040260816

Download citation: RISBibTeXText

PMID: 3308824


Related references

Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. Journal of Clinical Oncology 15(1): 11-17, 1997

Incidence and types of constitutional chromosomal abnormalities in patients with hematologic malignancies.. Korean Journal of Laboratory Medicine 26(1): 64-69, 2006

Hematologic disturbances in patients with nonhematologic neoplasms. I. Anemias. Przeglad Lekarski 52(8): 407-409, 1995

Causes of death in patients with nonhematologic malignancies. Cancer Chemotherapy Reports Part 1 57(1): 103, 1973

Detection of numerical chromosomal abnormalities in interphase cells from patients with hematologic malignancies by in situ hybridization ish. American Journal of Human Genetics 49(4 Suppl.): 239, 1991

Analysis of non-clonal chromosome abnormalities observed in hematologic malignancies among Southwest Oncology Group patients. American Journal of Human Genetics 55(3 Suppl. ): A301, 1994

Hematologic Malignancies/Pediatric Malignancies. Roles of Drugs Approved as New Agents and as Additional Indications for Relapse or Refractory Hematologic Malignancies. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 528-529, 2016

Hematologic disturbances in patients with nonhematologic neoplasms. II. Thrombosis, bleedings and leukemoid reaction. Przeglad Lekarski 52(8): 410-412, 1995

Nonhematologic malignancies in patients receiving myelo suppressive treatment for polycythemia vera. Clinical Research 30(2): 558A, 1982

Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial. Clinical Cancer Research 19(19): 5474-5484, 2013

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. Journal of Clinical Oncology 23(31): 7785-7793, 2005

Chromosomal abnormalities in myeloid hematologic malignancies. Current Topics in Microbiology and Immunology 149: 25-34, 1989

Trisomy 12 in Epstein-Barr virus-transformed lymphoblastoid cell lines of normal individuals and patients with nonhematologic malignancies. Cancer Genetics and Cytogenetics 60(2): 164-169, 1992

Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 805, 2010

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities. Blood Research 49(1): 22-28, 2014